Literature DB >> 1660788

Relationships between UMPK and PGD activities and deletions of chromosome 1p in colorectal cancers.

A Bravard1, C Luccioni, M Muleris, D Lefrancois, B Dutrillaux.   

Abstract

A deletion involving a large segment of the short arm of chromosome 1(1p-) occurs in about 50% of colorectal cancers. It was previously noticed that, in these tumors, many deletions affect genes encoding for enzymes of the de novo pathway of nucleotide synthesis. The gene for uridine monophosphate kinase (UMPK), mapped on 1p32, is generally involved in del(1p). The activity of the corresponding enzyme was measured and compared to that of 6-phosphogluconate dehydrogenase (PGD), encoded by a gene also mapped on chromosome 1p and frequently deleted, but involved in another metabolism. It was found that a clear relationship exists between activity and the number of chromosome 1p for PGD but not for UMPK, both on primary tumors (PTs) and on tumors grafted into nude mice (GTs). By comparison to corresponding normal mucosae, the activity of PGD was high in PTs and GTs, but this increase was reduced in case of del(1p). The activity of UMPK being increased in PTs but not in GTs, it is assumed that the increase in PTs is due to non-cancerous cells, which are missing in GTs. The fact that no gene dosage effect exists, although the tendency for del(1p) coexists with the relative decrease of UMPK activity in cancerous by comparison to non-cancerous cells, suggests that either mutation or disregulation of UMPK gene occurred early.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1660788     DOI: 10.1016/0165-4608(91)90361-w

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  8 in total

1.  Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis.

Authors:  Claire M Payne; Cheray Crowley-Skillicorn; Carol Bernstein; Hana Holubec; Harris Bernstein
Journal:  Clin Exp Gastroenterol       Date:  2011-05-03

2.  Lysine acetylation activates 6-phosphogluconate dehydrogenase to promote tumor growth.

Authors:  Changliang Shan; Shannon Elf; Quanjiang Ji; Hee-Bum Kang; Lu Zhou; Taro Hitosugi; Lingtao Jin; Ruiting Lin; Liang Zhang; Jae Ho Seo; Jianxin Xie; Meghan Tucker; Ting-Lei Gu; Jessica Sudderth; Lei Jiang; Ralph J DeBerardinis; Shaoxiong Wu; Yuancheng Li; Hui Mao; Peng R Chen; Dongsheng Wang; Georgia Zhuo Chen; Sagar Lonial; Martha L Arellano; Hanna J Khoury; Fadlo R Khuri; Benjamin H Lee; Daniel J Brat; Keqiang Ye; Titus J Boggon; Chuan He; Sumin Kang; Jun Fan; Jing Chen
Journal:  Mol Cell       Date:  2014-07-17       Impact factor: 17.970

3.  Discovery of Ebselen as an Inhibitor of 6PGD for Suppressing Tumor Growth.

Authors:  Qi Feng; Xiuru Li; Wenjing Sun; Yubo Li; Yu Yuan; Baozhang Guan; Shuai Zhang
Journal:  Cancer Manag Res       Date:  2020-08-05       Impact factor: 3.989

4.  Amplification of SKI is a prognostic marker in early colorectal cancer.

Authors:  Martin Buess; Luigi Terracciano; Jürgen Reuter; Pierluigi Ballabeni; Jean-Louis Boulay; Urban Laffer; Urs Metzger; Richard Herrmann; Christoph Rochlitz
Journal:  Neoplasia       Date:  2004 May-Jun       Impact factor: 5.715

5.  Inhibiting 6-phosphogluconate dehydrogenase selectively targets breast cancer through AMPK activation.

Authors:  Xiaoyu Yang; Xiaochun Peng; Jiangrong Huang
Journal:  Clin Transl Oncol       Date:  2018-01-16       Impact factor: 3.405

Review 6.  6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.

Authors:  Ruiting Lin; Shannon Elf; Changliang Shan; Hee-Bum Kang; Quanjiang Ji; Lu Zhou; Taro Hitosugi; Liang Zhang; Shuai Zhang; Jae Ho Seo; Jianxin Xie; Meghan Tucker; Ting-Lei Gu; Jessica Sudderth; Lei Jiang; Matthew Mitsche; Ralph J DeBerardinis; Shaoxiong Wu; Yuancheng Li; Hui Mao; Peng R Chen; Dongsheng Wang; Georgia Zhuo Chen; Selwyn J Hurwitz; Sagar Lonial; Martha L Arellano; Hanna J Khoury; Fadlo R Khuri; Benjamin H Lee; Qunying Lei; Daniel J Brat; Keqiang Ye; Titus J Boggon; Chuan He; Sumin Kang; Jun Fan; Jing Chen
Journal:  Nat Cell Biol       Date:  2015-10-19       Impact factor: 28.824

7.  1-Hydroxy-8-methoxy-anthraquinon Reverses Cisplatin Resistance by Inhibiting 6PGD in Cancer Cells.

Authors:  Huamin Zhang; Haowei Zhang; Sihui Wang; Zhihai Ni; Tiejun Wang
Journal:  Open Life Sci       Date:  2019-11-15       Impact factor: 0.938

8.  Purine and pyrimidine metabolism in human gliomas: relation to chromosomal aberrations.

Authors:  V Bardot; A M Dutrillaux; J Y Delattre; F Vega; M Poisson; B Dutrillaux; C Luccioni
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.